Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a life-threatening form of breast cancer which has been found to account for 15% of all the subtypes of breast cancer. Currently available treatments are significantly less effective in TNBC management because of several factors such as poor bioavailability, l...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Rajesh, Dey, Anuradha, Taliyan, Rajeev, Puri, Anu, Kharavtekar, Sanskruti, Dubey, Sunil Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866847/
https://www.ncbi.nlm.nih.gov/pubmed/36678877
http://dx.doi.org/10.3390/pharmaceutics15010246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866847/
https://www.ncbi.nlm.nih.gov/pubmed/36678877
http://dx.doi.org/10.3390/pharmaceutics15010246

Ejemplares similares